Genetic testing in ovarian cancer: getting better, and maybe not just for disease susceptibility anymore
- PMID: 22825078
- DOI: 10.1097/AOG.0b013e3182602599
Genetic testing in ovarian cancer: getting better, and maybe not just for disease susceptibility anymore
Comment on
-
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.Obstet Gynecol. 2012 Aug;120(2 Pt 1):235-40. doi: 10.1097/AOG.0b013e31825f3576. Obstet Gynecol. 2012. PMID: 22776961
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
